ARTICLE | Company News
Abgenix and SmithKline in XenoMouse deal
May 19, 2000 7:00 AM UTC
SBH will use ABGX's XenoMouse technology to generate human monoclonal antibodies to an undisclosed target. ABGX will receive a research license payment and could receive additional fees, milestones, a...